Company intelligence / Profile preview

California Center for Psychedelic Therapy

Los Angeles, California, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

California Center for Psychedelic Therapy is an operational mental health clinic in Los Angeles specializing in ketamine-assisted psychotherapy for treatment-resistant depression, and serves as a Phase II/III clinical trial site for MDMA-assisted therapy for PTSD[1][13][16]. It is recognized for its clinician-led, ethical, and experienced delivery of psychedelic-assisted therapies[1][16].

Therapeutic areas: OtherNeurologyPsychiatry
Modalities: Small moleculeNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Multidisciplinary Association for Psychedelic Studies (MAPS) (clinical trials)Psychedelic Science Institute (historical collaboration)[10]

Beyond the preview

Go deeper on California Center for Psychedelic Therapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on California Center for Psychedelic Therapy.

Explore the full profile